CIPO Patents = 10

EPO Patents = 4

Forward Citations = 6

Loading Chart...

7 inventors (with patents filed for the assignee):

Raphael J Mannino (6 out of 24 patents)

Ruying Lu (6 out of 11 patents)

Doug F Kling (1 out of 1 patent)

6 patents: Sort by Forward Citations

1. 12409227 - Cochleates made with soy phosphatidylserine (2025-09-09),

2. 11964019 - Cochleates made with soy phosphatidylserine (2024-04-23),

3. 11389407 - Cochleates and methods of using the same to enhance tissue penetration of pharmacologically active agent (2022-07-19),

4. 11123295 - Encholeated antifungal compounds for central nervous system delivery and treatment ofinfections (2021-09-21),

5. 10716860 - Cochleates made with soy phosphatidylserine (2020-07-21),

6. 9775907 - Cochleates made with soy phosphatidylserine (2017-10-03),

Matinas BioPharma is a clinical-stage biopharmaceutical company focused on developing innovative nanomedicines for the treatment of infectious diseases and cancer. Their proprietary lipid nanocrystal (LNC) platform technology enables the effective delivery of therapeutics, enhancing their bioavailability and targeting specific cells or tissues. With a strong pipeline of product candidates and partnerships with leading research institutions, Matinas BioPharma is dedicated to advancing the field of nanotechnology in medicine.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 2 2025

6 Patents

#9 in Bedminster, NJ

#1,653 in New Jersey

#43,729 in US

Bedminster, NJ, United States of America

Matinas Biopharma Nanotechnologies, Inc.

Forward Citations = 6

7 inventors:

Raphael J Mannino (6 out of 24 patents)

Ruying Lu (6 out of 11 patents)

Doug F Kling (1 out of 1 patent)

Please report any incorrect information to support@idiyas.com

10 patents (CIPO):

Please report any incorrect information to support@idiyas.com

4 patents (EPO):

Please report any incorrect information to support@idiyas.com